Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01475877
NCT01475877
Completed
Not Applicable

Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

Virdi Eye Clinic1 site in 1 country20 target enrollmentMay 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMyopia
InterventionsBromfenac
DrugsBromfenac

Overview

Phase
Not Applicable
Intervention
Bromfenac
Conditions
Myopia
Sponsor
Virdi Eye Clinic
Enrollment
20
Locations
1
Primary Endpoint
Post-PRK pain
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
May 2012
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •male or female at least 18 years of age,
  • •no other ocular studies with 15 days prior to dosing,
  • •BCVA 20/200 or better,
  • •return for study visits and follow instructions from investigator and staff,
  • •self administer test article

Exclusion Criteria

  • •Ocular inflammation,
  • •hypersensitivity to bromfenac or nepafenac,
  • •any corneal pathology,
  • •have had radial keratotomy,
  • •corneal transplant or corneal refractive surgery in the last two years

Arms & Interventions

Nepafenac

Intervention: Bromfenac

Outcomes

Primary Outcomes

Post-PRK pain

Time Frame: 7 days

Secondary Outcomes

  • Post-PRK epithelial healing(7 days)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
on-steroidal anti-inflammatory drugs vs Steroids in the post operative management of inflammation following uncomplicated cataract surgeryEye DiseasesSurgerycataract
PACTR201701001971511Dr Egagifo Ochuko100
Completed
Not Applicable
Anti-inflamation effect of Bromfenac ophthalmic solution after selective laser trabeculoplasty.Primary Open Angle Glaucoma
JPRN-UMIN000001172Kozawa Eye Hospital and Diabetes Center40
Completed
Phase 4
Bromfenac Versus Dexamethasone After Cataract SurgeryInflammation Eye
NCT03317847Azienda USL Reggio Emilia - IRCCS92
Unknown
Not Applicable
Observation on the Herpes Simplex KeratitisKeratitis, Herpetic
NCT03013959Peking Union Medical College100
Completed
Phase 4
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract SurgeryMacular Edema
NCT01395069Queen's University162